Bookmark and Share
Butyric Acid (CID 264) - Compound BioActivity Data
.
BioActivity Outcomes:
Active(10)
 
 
Inactive(161)
 
 
Inconclusive(30)
 
 
Unspecified(42)
 
 
Top Targets:
NR LBD PPAR(16)
 
 
 
NR LBD ER(14)
 
 
 
NR LBD AR(14)
 
 
 
NR LBD Fxr(8)
 
 
 
NR LBD GR(8)
 
 
 
BioAssay Types:
Confirmatory(124)
 
 
 
Literature(52)
 
 
 
 
Summary(48)
 
 
 
BioActivity Types:
Potency(160)
 
 
 
IC50(20)
 
 
 
Ki(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 157    Data Row: 243   Total Pages: 5   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID103176198]
IC50 9Inhibition of human recombinant HDAC3 [AID569930, Type: Literature]Histone deacetylase 3 [gi:3334210]
View
2
[SID103176198]
IC50 12Inhibition of human recombinant HDAC2 [AID569929, Type: Literature]Histone deacetylase 2 [gi:68068066]
View
3
[SID103176198]
IC50 15Inhibition of human recombinant HDAC8 [AID569931, Type: Literature]Histone deacetylase 8 [gi:29839394]
View
4
[SID103176198]
IC50 16Inhibition of human recombinant HDAC1 [AID569928, Type: Literature]Histone deacetylase 1 [gi:2498443]
View
5
[SID103176198]
Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS [AID347396, Type: Literature]
View
6
[SID103176198]
Increase in ROS production in human U251 cells at 100 uM after 4 hrs by FACS in presence of N-acetyl-L-cysteine [AID347397, Type: Literature]
View
7
[SID103176198]
Inhibition of 26S proteasome activity in human U251 cells at 0.5 mM after 24 hrs [AID347410, Type: Literature]
View
8
[SID74110]
NCI In Vivo Anticancer Drug Screen. Data for tumor model Mammary Adenocarcinoma CD8F1 (subcutaneous) in CD8F1 [AID220, Type: other]
View
9
[SID103176198]
Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in p21 mRNA level by qRT-PCR [AID412897, Type: Literature]
View
10
[SID103176198]
Inhibition of HDAC in human MDA-MB-231 cells assessed as increase in histone H3 acetylation after 3 days by densitometry [AID412899, Type: Literature]
View
11
[SID103176198]
Ki 81.2831Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr [AID360149, Type: Literature]Solute carrier family 22 member 20 [gi:56404586]
View
12
[SID103176198]
IC50 250Concentration required to inhibit the colony formation of pancreatic human (PACA) cell lines by 50% [AID154429, Type: Literature]
View
13
[SID103176198]
ED50 285In vitro for the differentiation induction activity determined in the human myeloid leukemic cell line HL-60 [AID81291, Type: Literature]
View
14
[SID103176198]
IC50 850Concentration required for 50% proliferation inhibition of myelomonocytic WEHI cell line [AID217956, Type: Literature]
View
15
[SID103176198]
IC50 932Cytotoxicity against human U251 cells after 72 hrs by Hoechst test [AID347392, Type: Literature]
View
16
[SID103176198]
IC50 933Inhibitory activity on growth of B16F10.9 melanoma cell line [AID41062, Type: Literature]
View
17
[SID103176198]
IC50 1000Concentration required to inhibit the colony formation of lung carcinoma (3LLD122) cell lines by 50% [AID3329, Type: Literature]
View
18
[SID103176198]
IC50 1525Concentration required for 50% proliferation inhibition of human promyelocytic HL-60 cell line [AID81447, Type: Literature]
View
19
[SID103176198]
IC50 2000Antiproliferative activity against human K562 cells [AID416474, Type: Literature]
View
20
[SID103176198]
IC50 2000Inhibition of human recombinant HDAC9 [AID569935, Type: Literature]Histone deacetylase 9 [gi:19865267]
View
21
[SID103176198]
IC50 2000Inhibition of human recombinant HDAC7 [AID569934, Type: Literature]Histone deacetylase 7 [gi:30913097]
View
22
[SID103176198]
IC50 2000Inhibition of human recombinant HDAC6 [AID569936, Type: Literature]Histone deacetylase 6 [gi:205371758]
View
23
[SID103176198]
IC50 2000Inhibition of human recombinant HDAC5 [AID569933, Type: Literature]Histone deacetylase 5 [gi:296434519]
View
24
[SID103176198]
IC50 2000Inhibition of human recombinant HDAC4 [AID569932, Type: Literature]Histone deacetylase 4 [gi:259016348]
View
25
[SID103176198]
IC50 2400Inhibition of cell growth against human myeloid leukemia K562(S) cells [AID95143, Type: Literature]
View
26
[SID103176198]
Ki 3467.37Inhibition of mouse Oat1-mediated [3H]PAH uptake in Xenopus oocytes after 1 hr [AID360150, Type: Literature]Solute carrier family 22 member 6 [gi:81901833]
View
27
[SID103176198]
IC50 10000Inhibition of 2-oxoglutarate-dependent human JMJD2E in presence of excess 2-oxoglutarate and 10 uM Fe2 by FDH coupled assay [AID344916, Type: Literature]
View
28
[SID103176198]
IC50 10000Inhibition of 2-oxoglutarate-dependent human JMJD2E in prescence of excess H3K9me3 peptide and 10 uM Fe2 by FDH coupled assay [AID344917, Type: Literature]
View
29
[SID103176198]
Protein interaction energy by using binding affinity towards human L-xylulose reductase enzyme [AID95754, Type: Literature]
View
30
[SID103176198]
Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system [AID237685, Type: Literature]
View
31
[SID103176198]
Inhibition of EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM [AID336938, Type: Literature]
View
32
[SID103176198]
Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced EBV-early antigen activation in human Raji cells assessed as early antigen activation at 4 mM ratio relative to TPA [AID336939, Type: Literature]
View
33
[SID103176198]
Evaluated for erythroid induction of benzidine-positive K562 cells at concentration 3 mM [AID94965, Type: Literature]
View
34
[SID103176198]
Partition coefficient (logP) [AID23251, Type: Literature]
View
35
[SID103176198]
Partition coefficient (logP) (benzene) [AID23252, Type: Literature]
View
36
[SID103176198]
Partition coefficient (logP) (carbon tetrachloride) [AID23253, Type: Literature]
View
37
[SID103176198]
Partition coefficient (logP) (chloroform) [AID23254, Type: Literature]
View
38
[SID103176198]
Partition coefficient (logP) (ether) [AID23255, Type: Literature]
View
39
[SID103176198]
Partition coefficient (logP) (hexane) [AID23256, Type: Literature]
View
40
[SID103176198]
Effect on appearance of B16F10.9 colonies in semisolid agar at 1 mM [AID41060, Type: Literature]
View
41
[SID103176198]
Induction of erythroid differentiation in human K562 cells assessed as benzidine-positive cells after 6 days [AID416475, Type: Literature]
View
42
[SID103176198]
IC50 Inhibition of HDAC in human Hela cells nuclear extracts by fluorimetric assay [AID447579, Type: Literature]
View
43
[SID103176198]
Toxicity in po dosed ICR mouse assessed as decreased in mobility after 3 hrs [AID498773, Type: Literature]
View
44
[SID103176198]
Toxicity in po dosed rat [AID498776, Type: Literature]
View
45
[SID103176198]
TP_TRANSPORTER: uptake of Butyric acid at a concentration of 137uM in MCT1-expressing MDA-MB231 cells [AID682070, Type: other]Monocarboxylate transporter 1 [gi:1709076]
View
46
[SID103176198]
Increase in heme level in human U251 cells at 100 uM after 48 hrs by western blot relative to control [AID347403, Type: Literature]
View
47
[SID103176198]
Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs relative to control [AID347412, Type: Literature]
View
48
[SID103176198]
Inhibition of 26S proteasome activity in human U251 cells at 100 uM after 48 hrs in presence of N-acetyl-L-cysteine relative to control [AID347413, Type: Literature]
View
49
[SID103176198]
Ratio of pKi for mouse Oat1 expressed in Xenopus oocytes to pKi for mouse Oat6 expressed in Xenopus oocytes [AID360151, Type: Literature]
View
50
[SID103176198]
Inhibition of erythroid differentiation in human K562 cell assessed benzidine positive cells at 2 mM after 6 days by benzidine staining assay [AID410585, Type: Literature]
View